Publications

Found 1695 results
Filters: First Letter Of Last Name is L  [Clear All Filters]
2026
Volynkina, I. A., Bortyazh, M. O., Chen, C. - W., Tereshchenkov, A. G., Karakchieva, A. O., Lukianov, D. A., Komarova, E. S., Tupikin, A. E., Skvortsov, D. A., Tevyashova, A. N., Tikhomirov, A. S., Tashlitsky, V. N., Kabilov, M. R., Shchekotikhin, A. E., Dontsova, O. A., Polikanov, Y. S., and Sergiev, P. V. (2026) Benzoxaborole-modified azithromycins inhibit translation without inducing expression. Antimicrob Agents Chemother. 10.1128/aac.01539-25
Kim, D., Woodbury, S. M., Ahern, W., Tischer, D., Kang, A., Joyce, E., Bera, A. K., Hanikel, N., Salike, S., Krishna, R., Yim, J., Pellock, S. J., Lauko, A., Kalvet, I., Hilvert, D., and Baker, D. (2026) Computational design of metallohydrolases. Nature. 649, 246-253
Smil, D., Liu, Y., Xin, T., Kiyota, T., Aman, A., Grouleff, J., Hoffer, L., Joshi, D. C., Inanlou, M. R., Song, S., Mao, D. Y. L., Ogunjimi, A. A., Pau, V., Chini, F. D., Kurinov, I., Zhang, Y., Nguyen, A. Thu, Wrana, J. L., Sicheri, F., Attisano, L., Uehling, D., Al-awar, R., and Isaac, M. B. (2026) Discovery and development of potent and selective dual NUAK/MARK inhibitors as Hippo pathway modulators for the treatment of cancer. Eur J Med Chem. 311, 118798
Landry, M. L., Malhotra, S., Beresini, M., Chan, C., Chan, E., de la Cruz, C. C., Endres, N. F., Evangelista, M., Gustafson, A., Hu, D., Hunsaker, T., Hsu, P., Izrayelit, Y., La, H., Larrocha, P. Saenz- Lope, Lian, Q., Merchant, M., Mao, J., Mroue, R., Oh, A., Plise, E., Shao, C., Siu, M., Tran, J. C., Wang, Y., Wang, W., Wei, B., Wong, S., Yen, C. - W., Zhou, Y., Purkey, H. E., Heffron, T. P., and Salphati, L. (2026) Discovery and Optimization of a Potent, Efficacious, and Brain-Penetrant Inhibitor of KRAS G12C. J Med Chem. 69, 5241-5258
Landry, M. L., Malhotra, S., Beresini, M., Chan, C., Chan, E., de la Cruz, C. C., Endres, N. F., Evangelista, M., Gustafson, A., Hu, D., Hunsaker, T., Hsu, P., Izrayelit, Y., La, H., Larrocha, P. Saenz- Lope, Lian, Q., Merchant, M., Mao, J., Mroue, R., Oh, A., Plise, E., Shao, C., Siu, M., Tran, J. C., Wang, Y., Wang, W., Wei, B., Wong, S., Yen, C. - W., Zhou, Y., Purkey, H. E., Heffron, T. P., and Salphati, L. (2026) Discovery and Optimization of a Potent, Efficacious, and Brain-Penetrant Inhibitor of KRAS G12C. J Med Chem. 69, 5241-5258
Landry, M. L., Malhotra, S., Beresini, M., Chan, C., Chan, E., de la Cruz, C. C., Endres, N. F., Evangelista, M., Gustafson, A., Hu, D., Hunsaker, T., Hsu, P., Izrayelit, Y., La, H., Larrocha, P. Saenz- Lope, Lian, Q., Merchant, M., Mao, J., Mroue, R., Oh, A., Plise, E., Shao, C., Siu, M., Tran, J. C., Wang, Y., Wang, W., Wei, B., Wong, S., Yen, C. - W., Zhou, Y., Purkey, H. E., Heffron, T. P., and Salphati, L. (2026) Discovery and Optimization of a Potent, Efficacious, and Brain-Penetrant Inhibitor of KRAS G12C. J Med Chem. 69, 5241-5258
Landry, M. L., Malhotra, S., Beresini, M., Chan, C., Chan, E., de la Cruz, C. C., Endres, N. F., Evangelista, M., Gustafson, A., Hu, D., Hunsaker, T., Hsu, P., Izrayelit, Y., La, H., Larrocha, P. Saenz- Lope, Lian, Q., Merchant, M., Mao, J., Mroue, R., Oh, A., Plise, E., Shao, C., Siu, M., Tran, J. C., Wang, Y., Wang, W., Wei, B., Wong, S., Yen, C. - W., Zhou, Y., Purkey, H. E., Heffron, T. P., and Salphati, L. (2026) Discovery and Optimization of a Potent, Efficacious, and Brain-Penetrant Inhibitor of KRAS G12C. J Med Chem. 69, 5241-5258
Chen, H., Dutta, R. Prasad, Li, Z., Zhong, Y., Ma, A., Park, K. - S., Kottur, J., Park, A., Babault, N., Wang, K., Wang, D., Xiong, Y., H Kaniskan, Ü., Luo, M., Parekh, S., and Jin, J. (2026) Discovery of a Potent, Selective, and In Vivo Efficacious Covalent Inhibitor for Lysine Methyltransferase SETD8. J Med Chem. 69, 4255-4269
Chen, H., Dutta, R. Prasad, Li, Z., Zhong, Y., Ma, A., Park, K. - S., Kottur, J., Park, A., Babault, N., Wang, K., Wang, D., Xiong, Y., H Kaniskan, Ü., Luo, M., Parekh, S., and Jin, J. (2026) Discovery of a Potent, Selective, and In Vivo Efficacious Covalent Inhibitor for Lysine Methyltransferase SETD8. J Med Chem. 69, 4255-4269
Shamir, Y., Gabizon, R., Rogel, A., Lin, D. Yin-wei, Andreotti, A. H., and London, N. (2026) Discovery of Covalent Ligands with AlphaFold3. J Am Chem Soc. 148, 13043-13054
Shamir, Y., Gabizon, R., Rogel, A., Lin, D. Yin-wei, Andreotti, A. H., and London, N. (2026) Discovery of Covalent Ligands with AlphaFold3. J Am Chem Soc. 148, 13043-13054
Yamaguchi, S., Fernandez, S. G., Wassarman, D. R., Lüders, M., Schwede, F., and Kranzusch, P. J. (2026) Nucleotide signals coordinate activation and inhibition of bacterial immunity. Nature. 652, 978-985
Hu, H., Zhang, Q., Ma, X., Chu, H. - F., Wang, H., Guo, Y., Bai, Y., Wang, Q., Li, Z., Zhao, J., Lin, H., You, C., Li, X., Tong, L., and Chen, X. (2026) Quantification and transcriptome profiling reveal abundant, dynamic and translatable dephospho-CoA-capped RNAs. Nat Biotechnol. 10.1038/s41587-026-03040-4
Hu, H., Zhang, Q., Ma, X., Chu, H. - F., Wang, H., Guo, Y., Bai, Y., Wang, Q., Li, Z., Zhao, J., Lin, H., You, C., Li, X., Tong, L., and Chen, X. (2026) Quantification and transcriptome profiling reveal abundant, dynamic and translatable dephospho-CoA-capped RNAs. Nat Biotechnol. 10.1038/s41587-026-03040-4
Hu, H., Zhang, Q., Ma, X., Chu, H. - F., Wang, H., Guo, Y., Bai, Y., Wang, Q., Li, Z., Zhao, J., Lin, H., You, C., Li, X., Tong, L., and Chen, X. (2026) Quantification and transcriptome profiling reveal abundant, dynamic and translatable dephospho-CoA-capped RNAs. Nat Biotechnol. 10.1038/s41587-026-03040-4
Lee, G. Rie, Pellock, S. J., Norn, C., Tischer, D., Dauparas, J., Anishchenko, I., Mercer, J. A. M., Kang, A., Bera, A. K., Nguyen, H., Brackenbrough, E., Sankaran, B., Goreshnik, I., Vafeados, D., Roullier, N., Han, H. L., Coventry, B., Haddox, H. K., Liu, D. R., Yeh, A. Hsien- Wei, and Baker, D. (2026) Small-molecule binding and sensing with a designed protein family. Nat Commun. 10.1038/s41467-026-70953-8
Lee, G. Rie, Pellock, S. J., Norn, C., Tischer, D., Dauparas, J., Anishchenko, I., Mercer, J. A. M., Kang, A., Bera, A. K., Nguyen, H., Brackenbrough, E., Sankaran, B., Goreshnik, I., Vafeados, D., Roullier, N., Han, H. L., Coventry, B., Haddox, H. K., Liu, D. R., Yeh, A. Hsien- Wei, and Baker, D. (2026) Small-molecule binding and sensing with a designed protein family. Nat Commun. 10.1038/s41467-026-70953-8
Shibata, S., Wang, M. Y., Imasaki, T., Shigematsu, H., La Torre, D. Ugarte, Wei, Y., Jobichen, C., Hagio, H., Sivaraman, J., Sugita, Y., Endow, S. A., and Nitta, R. (2026) Structural analysis of a motor with increased mechanical output reveals new transitions in kinesin microtubule motility. Sci Rep. 16, 487
Bhuket, P. Ratnatilak, Eastwood, J. R. B., Qin, Z., Kessler, J. L., Li, Y., Katz, D., Whitby, F. G., Hill, C. P., Kirshenbaum, K., and S Yu, M. (2026) Structural and Positional Effects of Peptoid Residues on Triple Helix Stability. Biomacromolecules. 10.1021/acs.biomac.5c02232
2025
Primi, M. C., Tavares, M. T., Hatcher, J. M., Kang, H., Kresina, T. A. C., Chakraborty, S., Leroy, E., Schmoker, A. M., Jeon, H., Weisberg, E. L., Akatsu, T., Griffin, J. D., Scott, D. A., and Eck, M. J. (2025) Allosteric inhibition of JAK2 with lysine-reactive compounds that bind the pseudokinase domain. Eur J Med Chem. 302, 118274
Nuthanakanti, A., Korn, M., Levenson-Palmer, R., Wu, Y., Babu, N. Rajesh, Huang, X., Banh, R. S., Belasco, J. G., and Serganov, A. (2025) ApaH decaps NpN-capped RNAs in two alternative orientations. Nat Chem Biol. 10.1038/s41589-025-01991-4
Simanshu, D. K., Xu, R., Stice, J. P., Czyzyk, D. J., Feng, S., Denson, J. - P., Riegler, E., Yang, Y., Zhang, C., Donovan, S., Smith, B. P., Abreu-Blanco, M., Chen, M., Feng, C., Fu, L., Rabara, D., Young, L. C., Dyba, M., Yan, W., Lin, K., Ghorbanpoorvalukolaie, S., Larsen, E. K., Malik, W., Champagne, A., Parker, K., Ju, J. Hyun, Jeknic, S., Esposito, D., Turner, D. M., Lightstone, F. C., Wang, B., Wehn, P. M., Wang, K., Stephen, A. G., Maciag, A. E., Hata, A. N., Sinkevicius, K. W., Nissley, D. V., Wallace, E. M., McCormick, F., and Beltran, P. J. (2025) BBO-10203 inhibits tumor growth without inducing hyperglycemia by blocking RAS-PI3Kα interaction.. Science. 10.1126/science.adq2004
Simanshu, D. K., Xu, R., Stice, J. P., Czyzyk, D. J., Feng, S., Denson, J. - P., Riegler, E., Yang, Y., Zhang, C., Donovan, S., Smith, B. P., Abreu-Blanco, M., Chen, M., Feng, C., Fu, L., Rabara, D., Young, L. C., Dyba, M., Yan, W., Lin, K., Ghorbanpoorvalukolaie, S., Larsen, E. K., Malik, W., Champagne, A., Parker, K., Ju, J. Hyun, Jeknic, S., Esposito, D., Turner, D. M., Lightstone, F. C., Wang, B., Wehn, P. M., Wang, K., Stephen, A. G., Maciag, A. E., Hata, A. N., Sinkevicius, K. W., Nissley, D. V., Wallace, E. M., McCormick, F., and Beltran, P. J. (2025) BBO-10203 inhibits tumor growth without inducing hyperglycemia by blocking RAS-PI3Kα interaction.. Science. 10.1126/science.adq2004
Simanshu, D. K., Xu, R., Stice, J. P., Czyzyk, D. J., Feng, S., Denson, J. - P., Riegler, E., Yang, Y., Zhang, C., Donovan, S., Smith, B. P., Abreu-Blanco, M., Chen, M., Feng, C., Fu, L., Rabara, D., Young, L. C., Dyba, M., Yan, W., Lin, K., Ghorbanpoorvalukolaie, S., Larsen, E. K., Malik, W., Champagne, A., Parker, K., Ju, J. Hyun, Jeknic, S., Esposito, D., Turner, D. M., Lightstone, F. C., Wang, B., Wehn, P. M., Wang, K., Stephen, A. G., Maciag, A. E., Hata, A. N., Sinkevicius, K. W., Nissley, D. V., Wallace, E. M., McCormick, F., and Beltran, P. J. (2025) BBO-10203 inhibits tumor growth without inducing hyperglycemia by blocking RAS-PI3Kα interaction.. Science. 10.1126/science.adq2004
Kröll-Hermi, A., Stoetzel, C., Etard, C., Halabelian, L., Schaefer, E., Scheidecker, S., Kahrizi, K., Payman, J., Geoffroy, V., Prasad, M., Obringer, C., Ruch, L., Girard, A., Zeng, H., Li, F., Plassard, D., Keime, C., Mattioli, F., Feger, C., Piton, A., Fujita, A., Matsumoto, N., Castro, M. Augusto Ar, Ae, K. Chong, Ruaud, L., Levy, J., Dozières, B., Tabet, A. - C., Wentzensen, I. M., Santiago-Sim, T., Yusupov, R., Tveten, K., Smeland, M. Falkenberg, Alkhunaizi, E., Cowing, G., Li, C., Wortmann, S. B., Feichtinger, R. G., Mayr, J. A., Gonorazky, H., Jing, G., Wang, X., Wang, J., Bierhals, T., Grinstein, L., Herget, T., Ruiz, A., Gabau, E., Kampmeier, A., Kassel, O., Kuechler, A., Platzer, K., Jamra, R. Abou, Woerner, A., Idleburg, M., Kircher, S. Gerit, Laccone, F., Golob, B., Peterlin, B., Čuturilo, G., Tasic, V., Kolvenbach, C. M., Hildebrandt, F., Ramos, L. L. P., Kok, F., Buck, C. Barbosa, van de Laar, I. M. B. H., de Man, S. A., Taşdelen, E., Sezer, A., Büke, A., Yavuz, Z., Çomoğlu, S. Selçuk, Costin, C., Them, F. Tran Mau, Lacaze, E., Courtin, T., Héron, D., Keren, B., Whalen, S., Roume, J., Yang, Y., Hoffer, M. J. V., van Haeringen, A., Najmabadi, H., Arrowsmith, C. H., Strähle, U., Dollfus, H., and Muller, J. (2025) Bi-allelic PRMT9 loss-of-function variants cause a syndromic form of intellectual disability. Am J Hum Genet. 10.1016/j.ajhg.2025.10.014

Pages